Showing 1 - 10 of 29
Persistent link: https://www.econbiz.de/10001381161
Persistent link: https://www.econbiz.de/10001704238
With increasing frequency, generic drug manufacturers in the United States are able to challenge the monopoly status of patent-protected drugs even before their patents expire. The legal foundation for these challenges is found in Paragraph IV of the Hatch-Waxman Act. If successful, these...
Persistent link: https://www.econbiz.de/10013037831
We view the political process in China as trading off the social benefits of increased trade and foreign direct investment, against the losses incurred by state-owned enterprises due to such liberalization. A model drawing on Grossman and Helpman (1994, 1996) is used to derive an empirically...
Persistent link: https://www.econbiz.de/10013226168
Persistent link: https://www.econbiz.de/10009234148
Persistent link: https://www.econbiz.de/10011665407
Persistent link: https://www.econbiz.de/10001441011
Persistent link: https://www.econbiz.de/10001722111
This paper develops a two-tier oligopoly model in which the entry of a multinational firm results in technology transfer to its local suppliers and also impacts the degree of backward linkages in the local industry. The model endogenizes the multinational's choice between anonymous market...
Persistent link: https://www.econbiz.de/10003029867
Persistent link: https://www.econbiz.de/10002703789